Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You can be male or female
- You must be between 18 and 60 years old (inclusive)
- You must have read, dated, and signed the consent form before any trial procedures begin (a legal guardian or curator can do this where applicable)
- You must be a member of, or covered by, a social security (health insurance) scheme
Who may not be able to join:
- People who have a diagnosed problem with using substances that affect the mind or mood (such as addiction or misuse disorders, as defined by standard medical guidelines)
- People who have recently used benzodiazepines (a type of sedative/anxiety medication), hallucinogens, or cannabis — specifically hallucinogens or benzodiazepines within a recent window based on how long the drug stays in the body, or cannabis within the 2 months before joining
- People who have a neurological condition (a disease or lasting damage affecting the brain or nervous system)
- People diagnosed with Attention Deficit Hyperactivity Disorder (ADHD)
- People diagnosed with borderline personality disorder
- People with significant sensory impairment, such as poor vision that cannot be corrected to a sufficient level (confirm with trial site)
- People who are currently under legal custody or court-ordered protection
- Women who are pregnant, in labour, or currently breastfeeding
- People who are currently participating in, or in an exclusion period from, another clinical trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Anne Giersch, MD PhD, Institut National de la Santé Et de la Recherche Médicale, France
Phone: 0033 3 88 116471
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Effect of a millisecond-level trajectory perturbation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.